Forsta AP Fonden Increases Holdings in Healthpeak Properties, Inc. (NYSE:DOC)

Forsta AP Fonden boosted its position in Healthpeak Properties, Inc. (NYSE:DOC) by 98.9% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 443,800 shares of the real estate investment trust’s stock after purchasing an additional 220,700 shares during the period. Forsta AP Fonden’s holdings in Healthpeak Properties were worth $8,996,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. HM Payson & Co. purchased a new stake in Healthpeak Properties in the third quarter valued at $25,000. S.A. Mason LLC purchased a new stake in Healthpeak Properties in the 3rd quarter worth approximately $26,000. Rise Advisors LLC acquired a new position in shares of Healthpeak Properties in the 3rd quarter valued at $29,000. Fortitude Family Office LLC purchased a new stake in Healthpeak Properties during the third quarter worth $32,000. Finally, Barrett & Company Inc. acquired a new stake in Healthpeak Properties during the third quarter valued at $33,000. Institutional investors and hedge funds own 93.57% of the company’s stock.

Healthpeak Properties Stock Performance

NYSE:DOC opened at $20.53 on Friday. Healthpeak Properties, Inc. has a fifty-two week low of $16.01 and a fifty-two week high of $23.26. The company has a debt-to-equity ratio of 0.93, a quick ratio of 1.31 and a current ratio of 1.31. The company has a 50 day moving average price of $20.79 and a 200 day moving average price of $21.55. The stock has a market capitalization of $14.36 billion, a P/E ratio of 43.67, a PEG ratio of 2.21 and a beta of 1.14.

Wall Street Analysts Forecast Growth

Several research firms have recently issued reports on DOC. Deutsche Bank Aktiengesellschaft raised shares of Healthpeak Properties from a “hold” rating to a “buy” rating and increased their target price for the stock from $20.00 to $28.00 in a research note on Monday, October 21st. Robert W. Baird upped their price objective on shares of Healthpeak Properties from $24.00 to $25.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 30th. Mizuho dropped their target price on shares of Healthpeak Properties from $25.00 to $24.00 and set an “outperform” rating on the stock in a research report on Thursday, December 5th. StockNews.com downgraded shares of Healthpeak Properties from a “hold” rating to a “sell” rating in a research report on Wednesday, October 30th. Finally, Morgan Stanley raised Healthpeak Properties from an “equal weight” rating to an “overweight” rating and set a $25.00 price target on the stock in a research note on Wednesday, January 15th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, Healthpeak Properties presently has an average rating of “Moderate Buy” and an average price target of $24.15.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.